Phase II study of saracatinib (AZD0530) in patients with previously treated metastatic colorectal cancer

Overview of attention for article published in Investigational New Drugs, June 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

So far, Altmetric has seen 1 X post from an account with 363 followers.

[VEGF] Phase II study of saracatinib (AZD0530) in patients with previously treated metastatic colorectal c... https://t.co/V8psFh2C8W PM